open access

Vol 77, No 2 (2009)
EDUKACJA. Zmniejszmy ciężar przewlekłej obturacyjnej choroby płuc (cz. II)
Published online: 2009-03-16
Submitted: 2013-02-22
Get Citation

Systemic features in chronic obstructive pulmonary disease

Halina Batura-Gabryel
Pneumonol Alergol Pol 2009;77(2):180-185.

open access

Vol 77, No 2 (2009)
EDUKACJA. Zmniejszmy ciężar przewlekłej obturacyjnej choroby płuc (cz. II)
Published online: 2009-03-16
Submitted: 2013-02-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Systemic features in chronic obstructive pulmonary disease

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 2 (2009)

Pages

180-185

Published online

2009-03-16

Bibliographic record

Pneumonol Alergol Pol 2009;77(2):180-185.

Authors

Halina Batura-Gabryel

References (43)
  1. Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6): 532–555.
  2. Agusti AGN. COPD, a multicomponent disease: implications for management. Respir Med. 2005; 99(6): 670–682.
  3. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: Role of comorbidities. Eur Respir J. 2006; 28(6): 1245–1257.
  4. Batura-Gabryel H, Kamińska-Kuźnar B. Nowe spojrzenie na przewlekłą obturacyjną chorobę płuc (POChP) — problem chorób współistniejących. Przew Lek. 2007; 3: 98–101.
  5. Fabbri LM, Luppi F, Beghé B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008; 31(1): 204–212.
  6. Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res. 2006; 7: 70.
  7. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998; 338(21): 1516–1520.
  8. Pinto-Plata VM, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006; 61(1): 23–28.
  9. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(4 Pt 1): 1179–1184.
  10. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7): 574–580.
  11. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007; 370(9589): 797–799.
  12. Batura-Gabryel H. Wpływ POChP na choroby współistniejące. Terapia. 2008; 9: 72–75.
  13. Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7): 574–580.
  14. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007; 13(5): 567–569.
  15. Agustí A, MacNee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component? Thorax. 2003; 58(10): 832–834.
  16. Similowski T, Agustí A, MacNee W, et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006; 27(2): 390–396.
  17. Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5(4): 549–555.
  18. Weel Cv. Chronic diseases in general practice: The longitudinal dimension. European Journal of General Practice. 2009; 2(1): 17–21.
  19. van Manen JG, Bindels PJ, IJzermans CJ, et al. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001; 54(3): 287–293.
  20. Viegi G, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007; 30(5): 993–1013.
  21. Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997; 10(12): 2794–2800.
  22. Soler JJ, Sánchez L, Román P, et al. [Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease]. Arch Bronconeumol. 2004; 40(6): 250–258.
  23. Kuźnar-Kamińska B, Batura-Gabryel H, Brajer B, et al. Ocena zaburzeń stanu odżywienia chorych na przewlekłą obturacyjną chorobę płuc. Pneumonol Alergol Pol. 2008; 5: 327–333.
  24. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996; 51(8): 819–824.
  25. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, et al. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162(4 Pt 1): 1239–1245.
  26. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med. 2000; 21(4): 753–762.
  27. Gosker HR, Hesselink MKC, Duimel H, et al. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J. 2007; 30(1): 73–79.
  28. Rabinovich RA, Bastos R, Ardite E, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J. 2007; 29(4): 643–650.
  29. Sidney S, Sorel M, Quesenberry C, et al. COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4): 2068–2075.
  30. Anthonisen NR, Connett JE, Enright PL, et al. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002; 166(3): 333–339.
  31. Maclay JD, McAllister DA, Mills NL, et al. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007; 12(5): 634–641.
  32. McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 176(12): 1208–1214.
  33. Mannino DM, Aguayo SM, Petty TL, et al. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003; 163(12): 1475–1480.
  34. Lange P, Nyboe J, Appleyard M, et al. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis. 1990; 141(3): 613–617.
  35. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003; 46: 64s–75s.
  36. Hill K, Geist R, Goldstein RS, et al. Anxiety and depression in end-stage COPD. Eur Respir J. 2008; 31(3): 667–677.
  37. Mikkelsen RL, Middelboe T, Pisinger C, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004; 58(1): 65–70.
  38. Jaracz J. Depresja i lęk w przewlekłych chorobach płuc. Przewodnik Lekarza. 2007(supl. 1): 139–141.
  39. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61(4): 284–289.
  40. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007; 29(5): 923–929.
  41. John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest. 2005; 127(3): 825–829.
  42. Mannino DM, Shorr AF, Doyle JJ, et al. Prevalence of anemia in subjects with chronic obstructive pulmonary disease. Proc. Am. Thorac Soc. 2006; 3: A615.
  43. Similowski T, Agustí A, MacNee W, et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006; 27(2): 390–396.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl